High Revenue Growth Stocks
Companies with year-over-year revenue growth exceeding 10%, indicating meaningful business expansion.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
1411 Companies Meeting Criteria
Showing 851–900 of 1411 companies, ranked by Revenue Growth.
| # | Company | Sector | Revenue Growth | Revenue |
|---|---|---|---|---|
| 851 | INCYIncyte | Health Care | 21.2% | $4.8B |
| 852 | MNRMACH NATURAL RESOURCES LP | Energy | 21.2% | $970M |
| 853 | FLLFULL HOUSE RESORTS INC | - | 21.2% | - |
| 854 | CFLTConfluent, Inc. | Information Technology | 21.1% | $1.1B |
| 855 | SCLXScilex Holding Co | - | 21.1% | - |
| 856 | UCTTUltra Clean Holdings, Inc. | Information Technology | 20.9% | $2.1B |
| 857 | ECVTEcovyst Inc. | Materials | 20.9% | $704M |
| 858 | FBRTFranklin BSP Realty Trust, Inc. | Financials | 20.9% | $210M |
| 859 | KTBKontoor Brands | Consumer Discretionary | 20.9% | $2.8B |
| 860 | GLTKGlobalTech Corp | - | 20.9% | - |
| 861 | NOWServiceNow | Information Technology | 20.9% | $12.7B |
| 862 | SNDKSandisk | Information Technology | 20.9% | $7.4B |
| 863 | QCRHQCR HOLDINGS INC | Financials | 20.7% | $166M |
| 864 | GDOTGREEN DOT CORP | Financials | 20.7% | $1.7B |
| 865 | AJGArthur J. Gallagher & Co. | Financials | 20.7% | $13.0B |
| 866 | DAWNDay One Biopharmaceuticals, Inc. | Health Care | 20.6% | - |
| 867 | DYAIDYADIC INTERNATIONAL INC | - | 20.6% | - |
| 868 | SIFSIFCO INDUSTRIES INC | - | 20.5% | - |
| 869 | INUVInuvo, Inc. | - | 20.5% | - |
| 870 | ISRGIntuitive Surgical | Health Care | 20.5% | $9.6B |
| 871 | AIFAAll In FutureTech Alliance, Inc. | - | 20.5% | - |
| 872 | WLDNWilldan Group, Inc. | Industrials | 20.5% | $566M |
| 873 | CEVACEVA INC | - | 20.4% | - |
| 874 | AUPHAurinia Pharmaceuticals Inc. | Health Care | 20.4% | $235M |
| 875 | FWRGFirst Watch Restaurant Group, Inc. | Consumer Discretionary | 20.3% | $1.0B |
| 876 | PWRQuanta Services | Industrials | 20.3% | $27.2B |
| 877 | NMRKNEWMARK GROUP, INC. | Real Estate | 20.3% | $2.7B |
| 878 | WULFTERAWULF INC. | Financials | 20.3% | $13M |
| 879 | CALXCalix | Information Technology | 20.3% | $934M |
| 880 | TDUPThredUp Inc. | Consumer Discretionary | 20.2% | $260M |
| 881 | AXGNAxogen, Inc. | Health Care | 20.2% | $187M |
| 882 | SIBNSI-BONE, Inc. | Health Care | 20.2% | $167M |
| 883 | RAREUltragenyx Pharmaceutical Inc. | Health Care | 20.2% | $631M |
| 884 | EACOEACO CORP | - | 20.1% | - |
| 885 | CTOCTO Realty Growth, Inc. | - | 20.1% | - |
| 886 | FOLDAMICUS THERAPEUTICS, INC. | Health Care | 20.0% | $528M |
| 887 | RDVTRed Violet, Inc. | Information Technology | 20.0% | $75M |
| 888 | BRWCBirdie Win Corp | - | 20.0% | - |
| 889 | MDXGMIMEDX GROUP, INC. | Health Care | 20.0% | $349M |
| 890 | MEDPMedpace | Health Care | 20.0% | $2.4B |
| 891 | WEAVWeave Communications, Inc. | - | 19.9% | - |
| 892 | COSMCosmos Health Inc. | - | 19.9% | - |
| 893 | UPBUpstream Bio, Inc. | Health Care | 19.9% | $2M |
| 894 | PSTLPostal Realty Trust, Inc. | - | 19.9% | - |
| 895 | BSXBoston Scientific | Health Care | 19.9% | $19.4B |
| 896 | DLPNDolphin Entertainment, Inc. | - | 19.9% | - |
| 897 | TNBITanke Biosciences Corp | - | 19.8% | - |
| 898 | NTSTNETSTREIT Corp. | Real Estate | 19.8% | $163M |
| 899 | RRXRegal Rexnord | Industrials | 19.8% | $6.3B |
| 900 | CPRXCatalyst Pharmaceuticals Partners, Inc. | Health Care | 19.8% | $492M |
Understanding Revenue Growth
Revenue growth above 10% is considered strong for large-cap companies. It typically signals increasing demand, successful new products, or geographic expansion. Growth rates are calculated from the two most recent annual SEC filings. One-time events like acquisitions can inflate growth temporarily.
YoY Revenue Growth > 10%
Results are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from screening.
Related Rankings
See the top companies ranked by these related metrics